Whereas, CXCL10- or CCL4-expressing pDCs were not found in pre-nRCT tumor samples, CXCL10+ pDCs were detectable in 14 out of 18 and CCL4+ pDCs in 12 out of 18 post-nRCT tumor samples (Figures 9A,B). This evidence concerns the gene CXCL10 and neoplasm.